$EBS
Emergent BioSolutions Inc.

2019 Q4 Form 10-Q Financial Statement

#000136764419000053 Filed on November 07, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $360.4M $311.8M $173.7M
YoY Change 33.14% 79.5% 16.27%
Cost Of Revenue $132.8M $108.0M $69.30M
YoY Change 30.32% 55.84% 55.73%
Gross Profit $77.80M $70.70M $21.30M
YoY Change 594.64% 231.92% -79.69%
Gross Profit Margin 21.59% 22.67% 12.26%
Selling, General & Admin $72.20M $65.00M $42.10M
YoY Change -10.53% 54.39% 27.96%
% of Gross Profit 92.8% 91.94% 197.65%
Research & Development $62.80M $53.40M $37.00M
YoY Change 20.77% 44.32% 63.0%
% of Gross Profit 80.72% 75.53% 173.71%
Depreciation & Amortization $27.90M $27.70M $12.40M
YoY Change 11.16% 123.39% 26.53%
% of Gross Profit 35.86% 39.18% 58.22%
Operating Expenses $149.8M $241.1M $152.3M
YoY Change -4.95% 58.31% 166.26%
Operating Profit $77.80M $70.70M $21.30M
YoY Change -153.14% 231.92% -55.35%
Interest Expense -$9.100M $10.30M $600.0K
YoY Change -1.09% 1616.67% -142.86%
% of Operating Profit -11.7% 14.57% 2.82%
Other Income/Expense, Net $2.900M -$11.80M $200.0K
YoY Change 81.25% -6000.0% -300.0%
Pretax Income $71.50M $58.90M $21.50M
YoY Change 1942.86% 173.95% -53.56%
Income Tax $24.60M $15.70M $600.0K
% Of Pretax Income 34.41% 26.66% 2.79%
Net Earnings $46.90M $43.20M $20.90M
YoY Change -1479.41% 106.7% -37.8%
Net Earnings / Revenue 13.01% 13.86% 12.03%
Basic Earnings Per Share $0.91 $0.84 $0.42
Diluted Earnings Per Share $0.90 $0.83 $0.41
COMMON SHARES
Basic Shares Outstanding 51.62M shares 51.60M shares 50.10M shares
Diluted Shares Outstanding 52.30M shares 51.50M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.8M $139.2M $339.4M
YoY Change 49.55% -58.99% -0.47%
Cash & Equivalents $167.8M $139.2M $340.4M
Short-Term Investments
Other Short-Term Assets $20.60M $49.40M $21.00M
YoY Change -35.02% 135.24% 25.0%
Inventory $222.5M $230.2M $125.7M
Prepaid Expenses
Receivables $270.7M $281.2M $77.00M
Other Receivables $4.600M $0.00 $0.00
Total Short-Term Assets $686.2M $700.0M $563.1M
YoY Change 10.53% 24.31% 1.28%
LONG-TERM ASSETS
Property, Plant & Equipment $542.3M $529.1M $435.1M
YoY Change 6.29% 21.6% 12.57%
Goodwill $266.6M $268.6M
YoY Change 2.66%
Intangibles $712.9M $727.7M
YoY Change -6.39%
Long-Term Investments
YoY Change
Other Assets $90.30M $67.40M $18.40M
YoY Change 559.12% 266.3% 60.0%
Total Long-Term Assets $1.641B $1.634B $610.5M
YoY Change 2.02% 167.62% 30.39%
TOTAL ASSETS
Total Short-Term Assets $686.2M $700.0M $563.1M
Total Long-Term Assets $1.641B $1.634B $610.5M
Total Assets $2.327B $2.334B $1.174B
YoY Change 4.39% 98.86% 14.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $94.80M $91.30M $38.90M
YoY Change 17.47% 134.7% 29.24%
Accrued Expenses $39.50M $51.80M $49.20M
YoY Change 28.66% 5.28% 34.79%
Deferred Revenue $3.300M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $12.90M $10.10M
YoY Change 27.72%
Total Short-Term Liabilities $216.3M $275.3M $102.0M
YoY Change 7.93% 169.9% 35.28%
LONG-TERM LIABILITIES
Long-Term Debt $798.4M $813.3M $13.50M
YoY Change 1.77% 5924.44% -94.58%
Other Long-Term Liabilities $48.60M $53.00M $91.50M
YoY Change -1.22% -42.08% 153.46%
Total Long-Term Liabilities $847.0M $866.3M $105.0M
YoY Change 1.6% 725.05% -63.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $216.3M $275.3M $102.0M
Total Long-Term Liabilities $847.0M $866.3M $105.0M
Total Liabilities $1.239B $1.299B $207.0M
YoY Change 1.67% 527.44% -42.58%
SHAREHOLDERS EQUITY
Retained Earnings $421.8M $374.9M
YoY Change 14.84%
Common Stock $100.0K $100.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $39.60M $39.70M
YoY Change 0.0%
Treasury Stock Shares 1.200M shares 1.200M shares
Shareholders Equity $1.089B $1.035B $966.6M
YoY Change
Total Liabilities & Shareholders Equity $2.327B $2.334B $1.174B
YoY Change 4.39% 98.86% 14.59%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income $46.90M $43.20M $20.90M
YoY Change -1479.41% 106.7% -37.8%
Depreciation, Depletion And Amortization $27.90M $27.70M $12.40M
YoY Change 11.16% 123.39% 26.53%
Cash From Operating Activities $122.1M -$3.100M $174.0M
YoY Change -173.64% -101.78% 398.57%
INVESTING ACTIVITIES
Capital Expenditures -$36.10M -$15.30M -$26.10M
YoY Change 73.56% -41.38% 103.91%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$36.10M -$15.30M -$26.10M
YoY Change -95.75% -41.38% 103.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -57.90M -19.70M 1.700M
YoY Change -107.37% -1258.82% -46.87%
NET CHANGE
Cash From Operating Activities 122.1M -3.100M 174.0M
Cash From Investing Activities -36.10M -15.30M -26.10M
Cash From Financing Activities -57.90M -19.70M 1.700M
Net Change In Cash 28.10M -38.10M 149.6M
YoY Change -112.31% -125.47% 491.3%
FREE CASH FLOW
Cash From Operating Activities $122.1M -$3.100M $174.0M
Capital Expenditures -$36.10M -$15.30M -$26.10M
Free Cash Flow $158.2M $12.20M $200.1M
YoY Change -209.1% -93.9% 319.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001367644
dei Entity Registrant Name
EntityRegistrantName
Emergent BioSolutions Inc.
CY2019Q2 ebs Debt Instrument Covenant Net Leverage Ratio Adjustment Period
DebtInstrumentCovenantNetLeverageRatioAdjustmentPeriod
P12M
CY2019Q2 ebs Debt Instrument Covenant Net Leverage Ratio Rolling Period
DebtInstrumentCovenantNetLeverageRatioRollingPeriod
P12M
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52400000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52800000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51200000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51600000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000.0 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000.0 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33137
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
14-1902018
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Professional Drive Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Gaithersburg,
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20879
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
631-3200
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.001 per share
dei Trading Symbol
TradingSymbol
EBS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51623596 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139200000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112200000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
200000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
200000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
510200000 USD
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
727700000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67400000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
281200000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
262500000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
230200000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
205800000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49200000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40100000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
700000000.0 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
620800000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
529100000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
761600000 USD
CY2019Q3 ebs In Process Research And Development
InProcessResearchAndDevelopment
41000000.0 USD
CY2018Q4 ebs In Process Research And Development
InProcessResearchAndDevelopment
50000000.0 USD
CY2019Q3 us-gaap Goodwill
Goodwill
268600000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
259700000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27100000 USD
CY2019Q3 us-gaap Assets
Assets
2333800000 USD
CY2018Q4 us-gaap Assets
Assets
2229400000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
91300000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
80700000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51800000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30700000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
55700000 USD
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5600000 USD
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
55800000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58200000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
10100000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
10100000 USD
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10600000 USD
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15100000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
275300000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
200400000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14500000 USD
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
54400000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
813300000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
784500000 USD
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
61100000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
67500000 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Liabilities
Liabilities
1218500000 USD
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
81600000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
62500000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
53000000.0 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49200000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
1298800000 USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
39700000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39600000 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
708800000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
688600000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9100000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5500000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
374900000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
367300000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1035000000.0 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1010900000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2333800000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2229400000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311800000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173600000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
745700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
511700000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108000000.0 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
69300000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
300700000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
208800000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53400000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
163400000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
90800000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65000000.0 USD
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42100000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
201300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
121800000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
70700000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14700000 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000 USD
us-gaap Operating Expenses
OperatingExpenses
433100000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11700000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
241100000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
152300000 USD
us-gaap Operating Expenses
OperatingExpenses
709300000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
21300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
36400000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
78600000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
10300000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
600000 USD
us-gaap Interest Expense
InterestExpense
29300000 USD
us-gaap Interest Expense
InterestExpense
1800000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1500000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
800000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1200000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1200000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11800000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
200000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30500000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-600000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
58900000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
78000000.0 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15700000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11800000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
20900000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51600000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49900000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
43200000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
20900000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1100000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-200000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
600000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000000.0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
3000000.0 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
4200000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4100000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3600000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000.0 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39100000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4000000.0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65200000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
21000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
16700000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82800000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37100000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2200000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5700000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12800000 USD
ebs Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
12400000 USD
ebs Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
1900000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-700000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18600000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-66500000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24400000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17100000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
36500000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16100000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2500000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5700000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5200000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2500000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2400000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3900000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
19100000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3200000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65900000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
207600000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51300000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
10000000.0 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
0 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2600000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60800000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48700000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
130000000.0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
95000000.0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
8400000 USD
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5700000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11400000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6600000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6300000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3700000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2200000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22000000.0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2800000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-100000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-600000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27000000.0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
161100000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112400000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179300000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139400000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
340400000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1010900000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20100000 USD
us-gaap Net Income Loss
NetIncomeLoss
7600000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3600000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1035000000.0 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
988900000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000.0 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
43200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4100000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1035000000.0 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
912200000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-32500000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1
879700000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21700000 USD
us-gaap Net Income Loss
NetIncomeLoss
66200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000.0 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
966600000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
938400000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7500000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
20900000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-200000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
966600000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2019Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
34600000 USD
CY2018Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
0 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="line-height:120%;padding-bottom:8px;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#000000;font-weight:normal;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. Interest income, which was previously reported as a separate line item on the condensed consolidated statement of operations has been combined with other income (expense), net. </span></div>
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Consideration Transferred
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
0 USD
CY2019Q3 ebs Number Of Business Acquisitions
NumberOfBusinessAcquisitions
2 acquisition
CY2019Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
69000000.0 USD
CY2018Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
51800000 USD
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
106600000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
103200000 USD
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
54600000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
50800000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
230200000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
205800000 USD
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
729100000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
681700000 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200000000.0 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
171500000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
529100000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
510200000 USD
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
ebs Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
800000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2100000 USD
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
100000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
400000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
900000 USD
us-gaap Lease Cost
LeaseCost
2500000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19400000 USD
CY2019Q3 ebs Operating Lease Other Liability Current
OperatingLeaseOtherLiabilityCurrent
2500000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17400000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
19900000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M18D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
818400000 USD
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
10000000.0 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
828400000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
100700000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
727700000 USD
CY2018Q4 us-gaap Goodwill Gross
GoodwillGross
259700000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
8900000 USD
CY2019Q3 us-gaap Goodwill Gross
GoodwillGross
268600000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
268600000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
151400000 USD
CY2018 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
667000000.0 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
818400000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
56800000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
761600000 USD
CY2017Q4 us-gaap Goodwill Gross
GoodwillGross
49100000 USD
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
210600000 USD
CY2018Q4 us-gaap Goodwill Gross
GoodwillGross
259700000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
259700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11700000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14700000 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000 USD
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P13Y9M18D
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
60000000.0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
10000000.0 USD
ebs Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Measurement Period Adjustment
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityMeasurementPeriodAdjustment
1500000 USD
ebs Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Change In Fair Value
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue
12400000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
13700000 USD
CY2019Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
70200000 USD
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
835400000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
808800000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
10100000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
10100000 USD
CY2019Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
12000000.0 USD
CY2018Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
14200000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
813300000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
784500000 USD
CY2019Q2 ebs Debt Instrument Covenant Debt Service Coverage Ratio
DebtInstrumentCovenantDebtServiceCoverageRatio
2.50
CY2019Q2 ebs Debt Instrument Covenant Net Leverage Ratio One
DebtInstrumentCovenantNetLeverageRatioOne
4.95
CY2019Q2 ebs Debt Instrument Covenant Net Leverage Ratio Two
DebtInstrumentCovenantNetLeverageRatioTwo
4.75
CY2019Q2 ebs Debt Instrument Covenant Net Leverage Ratio Three
DebtInstrumentCovenantNetLeverageRatioThree
3.75
CY2019Q2 ebs Debt Instrument Covenant Net Leverage Ratio Four
DebtInstrumentCovenantNetLeverageRatioFour
3.50
CY2019Q2 ebs Debt Instrument Covenant Net Leverage Ratio Adjusted
DebtInstrumentCovenantNetLeverageRatioAdjusted
4.00
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
311800000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173600000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
745700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
511700000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
73100000 USD
ebs Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
34600000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18100000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
89600000 USD
CY2019Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
659600000 USD
CY2019Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2019Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
27300000 USD
CY2018Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
1200000 USD
CY2019Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
251400000 USD
CY2018Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
234000000.0 USD
CY2019Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
29800000 USD
CY2018Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
28500000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
281200000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
262500000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.26
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000.0 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
8700000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-200000 USD
CY2018Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5500000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
43200000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
20900000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7600000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
66200000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51600000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1300000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49900000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
700000 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
900000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51200000 shares
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000.0 shares
CY2019Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
300000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1000000.0 USD
CY2019Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
100000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
400000 USD
CY2019Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
200000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
600000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139200000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112200000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
200000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
200000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139400000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112400000 USD

Files In Submission

Name View Source Status
0001367644-19-000053-index-headers.html Edgar Link pending
0001367644-19-000053-index.html Edgar Link pending
0001367644-19-000053.txt Edgar Link pending
0001367644-19-000053-xbrl.zip Edgar Link pending
acam2000.htm Edgar Link pending
acam2000001.jpg Edgar Link pending
acam2000002.jpg Edgar Link pending
acam2000003.jpg Edgar Link pending
acam2000004.jpg Edgar Link pending
acam2000005.jpg Edgar Link pending
bardassleditsv4.htm Edgar Link pending
bardassleditsv4001.jpg Edgar Link pending
bardassleditsv4002.jpg Edgar Link pending
bardassleditsv4003.jpg Edgar Link pending
bardassleditsv4004.jpg Edgar Link pending
bardassleditsv4005.jpg Edgar Link pending
bardassleditsv4006.jpg Edgar Link pending
bardassleditsv4007.jpg Edgar Link pending
bardassleditsv4008.jpg Edgar Link pending
bardassleditsv4009.jpg Edgar Link pending
bardassleditsv4010.jpg Edgar Link pending
bardassleditsv4011.jpg Edgar Link pending
bardassleditsv4012.jpg Edgar Link pending
bardassleditsv4013.jpg Edgar Link pending
bardassleditsv4014.jpg Edgar Link pending
bardassleditsv4015.jpg Edgar Link pending
chart-08c3200648a85bfbb02.jpg Edgar Link pending
chart-30e79593338b5b55bb1.jpg Edgar Link pending
chart-36aa92ebca8b544ba6c.jpg Edgar Link pending
chart-7ee770ef88d0558a90c.jpg Edgar Link pending
chart-b93f4b16de0d57ea86f.jpg Edgar Link pending
chart-e5372df7d8f15b08af6.jpg Edgar Link pending
ebs-20190930.xsd Edgar Link pending
ebs-20190930x10q.htm Edgar Link pending
ebs-20190930x10q_htm.xml Edgar Link completed
ebs-20190930xex311.htm Edgar Link pending
ebs-20190930xex312.htm Edgar Link pending
ebs-20190930xex321.htm Edgar Link pending
ebs-20190930xex322.htm Edgar Link pending
ebs-20190930_cal.xml Edgar Link unprocessable
ebs-20190930_def.xml Edgar Link unprocessable
ebs-20190930_lab.xml Edgar Link unprocessable
ebs-20190930_pre.xml Edgar Link unprocessable
emergentlogocmykregistered.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending